| PRECLINICAL | evidence | Female Sexual Desire, Arousal, and Orgasmic Dysfunctions: A Systematic Review and Meta-Analysis of Treatment Options. | Bremelanotide | Sexual function & libido | 2026-01-01 |
| PRECLINICAL | evidence | Practical considerations and emerging approaches for the management of vasomotor and sexual symptoms in breast cancer patients on endocrine therapies. | Bremelanotide | Sexual function & libido | 2025-10-01 |
| PRECLINICAL | evidence | Polymorphism of Melanocortin Receptor Genes-Association with Inflammatory Traits and Diseases. | Bremelanotide | — | 2025-09-16 |
| PRECLINICAL | evidence | 2024 SOGC, 2024 NCCN, 2022 ESO-ESMO, and 2018 ASCO: a comparison of female cancer survivorship guidelines for the management of sexual health concerns. | Bremelanotide | Sexual function & libido | 2025-06-15 |
| PRECLINICAL | evidence | Intravenous peptides and amino acids for erectile dysfunction: a narrative review of current applications and future directions. | PT 141 | — | 2025-04-01 |
| PRECLINICAL | evidence | Novel Pharmacologic Treatments of Female Sexual Dysfunction. | Bremelanotide | Sexual function & libido | 2025-03-01 |
| PRECLINICAL | evidence | Pharmacotherapy of Hypoactive Sexual Desire Disorder in Premenopausal Women. | Bremelanotide | Sexual function & libido | 2025-02-01 |
| PRECLINICAL | evidence | FDA-approved drugs as potential covalent inhibitors of key SARS-CoV-2 proteins: an in silico approach. | Bremelanotide | — | 2025-01-01 |
| PRECLINICAL | evidence | Melanocortin Receptor Agonist Bremelanotide Induces Cell Death and Growth Inhibition in Glioblastoma Cells via Suppression of Survivin Expression. | Bremelanotide | preclinical | 2024-09-01 |
| PRECLINICAL | evidence | Understanding the Interplay Between Premenstrual Dysphoric Disorder (PMDD) and Female Sexual Dysfunction (FSD). | Bremelanotide | — | 2024-06-01 |
| PRECLINICAL | evidence | Small Effects, Questionable Outcomes: Bremelanotide for Hypoactive Sexual Desire Disorder. | Bremelanotide | Sexual function & libido | 2024-05-01 |
| PRECLINICAL | evidence | A Comprehensive Review of Novel FDA-Approved Psychiatric Medications (2018-2022). | Bremelanotide | — | 2024-03-01 |
| PRECLINICAL | evidence | What Women Want? The State of the Art regarding the Treatment of Young Women with Hypoactive Sexual Desire Disorder. | Bremelanotide | Sexual function & libido | 2024-01-01 |
| PRECLINICAL | evidence | First-time orgasm in a young man with lifelong anorgasmia after flibanserin use: a case report. | Bremelanotide | — | 2023-12-01 |
| PRECLINICAL | evidence | Understanding Hypoactive Sexual Desire Disorder (HSDD) in Women: Etiology, Diagnosis, and Treatment. | Bremelanotide | — | 2023-11-01 |
| PRECLINICAL | evidence | Targeting the central melanocortin system for the treatment of metabolic disorders. | Bremelanotide | — | 2023-09-01 |
| PRECLINICAL | evidence | Expression of Concern: Salvage of Sildenafil Failures With Bremelanotide: A Randomized, Double-Blind, Placebo Controlled Study. | Bremelanotide | — | 2023-01-10 |
| PRECLINICAL | evidence | Pharmacotherapy for female sexual dysfunctions (FSDs): what is on the market and where is this field heading? | Bremelanotide | Sexual function & libido | 2023-01-01 |
| PRECLINICAL | evidence | An evaluation of bremelanotide injection for the treatment of hypoactive sexual desire disorder. | Vyleesi | Sexual function & libido | 2023-01-01 |
| PRECLINICAL | evidence | Pharmacologic therapeutic options for sexual dysfunction. | Bremelanotide | Sexual function & libido | 2022-12-01 |
| PRECLINICAL | evidence | Ligands for Melanocortin Receptors: Beyond Melanocyte-Stimulating Hormones and Adrenocorticotropin. | Bremelanotide | Pigmentation | 2022-10-01 |
| PRECLINICAL | evidence | Finding Our Way From the Bench to the Bedside: The Ethos, Logos, and Pathos of Biomedical Research. | Bremelanotide | — | 2022-07-01 |
| PRECLINICAL | evidence | The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder in premenopausal women. | Bremelanotide | Sexual function & libido | 2022-06-01 |
| PRECLINICAL | evidence | Female sexual dysfunctions: an overview on the available therapeutic interventions. | Bremelanotide | Sexual function & libido | 2022-06-01 |
| PRECLINICAL | evidence | Management of Hypertension with Female Sexual Dysfunction. | Bremelanotide | — | 2022-05-05 |
| PRECLINICAL | evidence | Medical Treatment of Female Sexual Dysfunction. | Bremelanotide | Sexual function & libido | 2022-05-01 |
| PRECLINICAL | evidence | Pharmacotherapy for Sexual Dysfunction in Women. | Bremelanotide | Sexual function & libido | 2022-02-01 |
| PRECLINICAL | evidence | Bremelanotide for Treatment of Female Hypoactive Sexual Desire. | Bremelanotide | — | 2022-01-04 |
| PRECLINICAL | evidence | Bremelanotide and flibanserin for low sexual desire in women: the fallacy of regulatory precedent. | Vyleesi | Sexual function & libido | 2021-12-01 |
| PRECLINICAL | evidence | Re-Analyzing Phase III Bremelanotide Trials for "Hypoactive Sexual Desire Disorder" in Women. | Bremelanotide | Sexual function & libido | 2021-11-01 |
| PRECLINICAL | evidence | Failure of a Meta-analysis: A Commentary on Glen Spielmans's "Re-Analyzing Phase III Bremelanotide Trials for 'Hypoactive Sexual Desire Disorder in Women'". | Bremelanotide | Sexual function & libido | 2021-11-01 |
| PRECLINICAL | evidence | Structural insights into ligand recognition and activation of the melanocortin-4 receptor. | Vyleesi | Weight & fat loss · preclinical | 2021-11-01 |
| PRECLINICAL | evidence | Hypoactive Sexual Desire Disorder in Women: Physiology, Assessment, Diagnosis, and Treatment. | Bremelanotide | Sexual function & libido | 2021-11-01 |
| PRECLINICAL | evidence | Psychometric validation of the Female Sexual Distress Scale-Desire/Arousal/Orgasm. | Bremelanotide | — | 2021-09-24 |
| PRECLINICAL | evidence | LC-HRMS characterization of the skin pigmentation and sexual enhancers melanotan II and bremelanotide sold on the black market of performance and image enhancing drugs. | Bremelanotide | — | 2021-04-01 |
| PRECLINICAL | evidence | Management of hypoactive sexual desire disorder in transgender women: a guide for clinicians. | Bremelanotide | Sexual function & libido | 2020-11-01 |
| PRECLINICAL | evidence | Reliability and validity of the elements of desire questionnaire in premenopausal women with hypoactive sexual desire disorder. | Bremelanotide | — | 2020-10-08 |
| PRECLINICAL | evidence | Female Hypoactive Sexual Desire Disorder: A Practical Guide to Causes, Clinical Diagnosis, and Treatment. | Bremelanotide | Sexual function & libido | 2020-08-01 |
| PRECLINICAL | evidence | Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder. | Vyleesi | Sexual function & libido | 2020-07-01 |
| PRECLINICAL | evidence | New Drugs 2020, part 2. | Bremelanotide | — | 2020-05-01 |
| PRECLINICAL | evidence | 2019 FDA TIDES (Peptides and Oligonucleotides) Harvest. | Bremelanotide | — | 2020-03-05 |
| PRECLINICAL | evidence | Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder. | Bremelanotide | Sexual function & libido | 2019-11-01 |
| PRECLINICAL | evidence | Boosting Female Sexual Response by RECONNECTing the Dots. | Bremelanotide | Sexual function & libido | 2019-11-01 |
| PRECLINICAL | evidence | New Drug for Hypoactive Sexual Desire Disorder in Premenopausal Women. | Bremelanotide | Sexual function & libido | 2019-10-01 |
| PRECLINICAL | evidence | Bremelanotide: First Approval. | Vyleesi | Sexual function & libido | 2019-09-01 |
| PRECLINICAL | evidence | Bremelanotide (Vyleesi) for hypoactive sexual desire disorder. | Vyleesi | Sexual function & libido | 2019-07-29 |
| PRECLINICAL | evidence | What are the challenges in prescribing pharmacotherapy for female sexual dysfunctions? | Bremelanotide | — | 2019-05-01 |
| PRECLINICAL | evidence | Expert opinion on existing and developing drugs to treat female sexual dysfunction. | Bremelanotide | Sexual function & libido | 2018-09-01 |
| PRECLINICAL | evidence | Female Sexual Dysfunction and the Placebo Effect: A Meta-analysis. | Bremelanotide | Sexual function & libido | 2018-08-01 |
| PRECLINICAL | evidence | Effect Size in Efficacy Trials of Women With Decreased Sexual Desire. | Bremelanotide | Sexual function & libido | 2018-07-01 |